Core-shell nanoparticulate formulation of gemcitabine: lyophilization, stability studies, and in vivo evaluation

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Drug Delivery and Translational Research

• Publication date

  2014-10-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s13346-014-0206-yPMID 25787206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanocarriers as an Emerging Platform for Cancer Therapy

  2020cited by this paper
• Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer

  2014cited by this paper
• Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer.

  2014cited by this paper
• Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing for efficient antitumor activity.

  2013cited by this paper
• Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells

  2013cited by this paper
• Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer.

  2013influential reference
• Self-assembling, amphiphilic polymer-gemcitabine conjugate shows enhanced antitumor efficacy against human pancreatic adenocarcinoma.

  2013cited by this paper
• BSA-PLGA-Based Core-Shell Nanoparticles as Carrier System for Water-Soluble Drugs

  2013cited by this paper
• An insight into potential of nanoparticles-assisted chemotherapy of cancer using gemcitabine and its fatty acid prodrug:a comparative study.

  2013cited by this paper
• Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study

  2012cited by this paper
• Role of chitosan nanoparticles in the oral absorption of Gemcitabine.

  2012cited by this paper
• Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells

  2012cited by this paper
• Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model

  2012cited by this paper
• Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer.

  2012cited by this paper
• Characterization of biomolecular nanoconjugates by high-throughput delivery and spectroscopic difference.

  2012cited by this paper
• A systematic study on lyophilization process of polymersomes for long-term storage using doxorubicin-loaded (PEG)₃-PLA nanopolymersomes.

  2012cited by this paper
• EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer.

  2011cited by this paper
• Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.

  2011cited by this paper
• Effects of Transport Inhibitors on the Cellular Uptake of Carboxylated Polystyrene Nanoparticles in Different Cell Lines

  2011cited by this paper
• Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine.

  2010cited by this paper
• In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer

  2009cited by this paper
• Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine

  2009cited by this paper
• Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro

  2009cited by this paper
• Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate.

  2009cited by this paper
• Novel approaches to deliver gemcitabine to cancers.

  2008cited by this paper
• Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs.

  2008cited by this paper
• A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging

  2008cited by this paper
• Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes

  2008cited by this paper
• Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.

  2008influential reference
• Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells.

  2008cited by this paper
• 9-Nitrocamptothecin polymeric nanoparticles: cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats

  2008influential reference
• Magnetic poly ε-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model

  2007cited by this paper
• Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.

  2007cited by this paper
• Nanocarriers as an emerging platform for cancer therapy.

  2007cited by this paper
• Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK).

  2007cited by this paper
• Magnetic poly epsilon-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model.

  2007cited by this paper
• Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.

  2006cited by this paper
• Preparation of poly ɛ-caprolactone nanoparticles containing magnetite for magnetic drug carrier

  2006cited by this paper
• Magnetic PECA nanoparticles as drug carriers for targeted delivery: Synthesis and release characteristics

  2006cited by this paper
• Efficient gene transfection using chitosan–alginate core-shell nanoparticles

  2006cited by this paper
• Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier.

  2006cited by this paper
• Folate-mediated targeting of polymeric conjugates of gemcitabine.

  2006cited by this paper
• Freeze-drying of nanoparticles: formulation, process and storage considerations.

  2006cited by this paper
• Pharmacokinetics and biodistribution studies of Doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques.

  2004influential reference
• Cytotoxic effects of Gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells

  2004cited by this paper
• Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration.

  2002cited by this paper
• Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels

  2002influential reference
• Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer.

  1999cited by this paper
• Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell Uptake

  1999cited by this paper

• Synthesis and optimization of gemcitabine-loaded nanoparticles by using Box–Behnken design for treating prostate cancer: In vitro characterization and in vivo pharmacokinetic study

  2025cites this paper
• Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: a state-of-the-art review

  2023cites this paper
• Preparation of Biodegradable Polymeric Nanocapsules for Treatment of Malignant Tumor Using Coaxial Capillary Microfluidic Device

  2020cites this paper
• Aspartic acid tagged carbon nanotubols as a tool to deliver docetaxel to breast cancer cells: Reduced hemotoxicity with improved cytotoxicity.

  2019cites this paper
• A novel PEGylated carbon nanotube conjugated mangiferin: An explorative nanomedicine for brain cancer cells

  2019cites this paper
• Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo

  2017cites this paper
• Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.

  2017cites this paper
• Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy.

  2016cites this paper
• AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.

  2016cites this paper
• Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.

  2016cites this paper